CD8A and neoplasm: Matched pre and on-treatment biopsies issued from clinical studies show the action of PD-1 blockade on the tumor to translate into a marked intratumoral expansion of CD8 + effector T cells coinciding with a change in gradient of CD8 + T cell density from the tumor margins into its center [95–97].